140 related articles for article (PubMed ID: 2551474)
1. Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide.
Theodore C; Azab M; Droz JP; Assouline A; George M; Piot G; Bellet D; Michel G; Amiel JL
Cancer; 1989 Nov; 64(9):1824-8. PubMed ID: 2551474
[TBL] [Abstract][Full Text] [Related]
2. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
3. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
[TBL] [Abstract][Full Text] [Related]
4. Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease.
Soper JT; Evans AC; Rodriguez G; Berchuck A; Clarke-Pearson DL; Hammond CB
Gynecol Oncol; 1995 Mar; 56(3):421-4. PubMed ID: 7705678
[TBL] [Abstract][Full Text] [Related]
5. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
6. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
Dobson LS; Lorigan PC; Coleman RE; Hancock BW
Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
[TBL] [Abstract][Full Text] [Related]
7. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
[No Abstract] [Full Text] [Related]
8. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for gestational trophoblastic tumors.
Takamizawa H; Sekiya S; Kobayashi O; Matsui H
Semin Surg Oncol; 1987; 3(1):36-44. PubMed ID: 3027827
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin.
Willemse PH; Aalders JG; Bouma J; Sleijfer DT
Obstet Gynecol; 1988 Mar; 71(3 Pt 2):438-40. PubMed ID: 2450325
[TBL] [Abstract][Full Text] [Related]
11. Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
Schink JC; Singh DK; Rademaker AW; Miller DS; Lurain JR
Obstet Gynecol; 1992 Nov; 80(5):817-20. PubMed ID: 1328977
[TBL] [Abstract][Full Text] [Related]
12. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
13. Poor-prognosis gestational trophoblastic disease: an update.
Surwit EA; Alberts DS; Christian CD; Graham VE
Obstet Gynecol; 1984 Jul; 64(1):21-6. PubMed ID: 6204257
[TBL] [Abstract][Full Text] [Related]
14. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
Mao Y; Wan X; Lv W; Xie X
Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
[TBL] [Abstract][Full Text] [Related]
15. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C
Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417
[TBL] [Abstract][Full Text] [Related]
16. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
[TBL] [Abstract][Full Text] [Related]
17. Liver metastases of gestational trophoblastic tumor.
Bakri YN; Subhi J; Amer M; Ezzat A; Sinner W; Tweijry A; Jabbar FA
Gynecol Oncol; 1993 Jan; 48(1):110-3. PubMed ID: 8380786
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease.
Gordon AN; Kavanagh JJ; Gershenson DM; Saul PB; Copeland LJ; Stringer CA
Cancer; 1986 Oct; 58(7):1407-10. PubMed ID: 2427185
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
20. Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy.
Gillespie AM; Kumar S; Hancock BW
Br J Cancer; 2000 Apr; 82(8):1393-5. PubMed ID: 10780516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
